unoprostone
Sign in to saveAlso known as RSC021, 13,14-dihydro-15-keto-20-ethyl PGF2α, (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]hept-5-enoic acid, (+)-(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl)-5-heptenoic acid, 13,14-dihydro-15-keto-20-ethyl PGF2alpha
Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone isopropyl, was marketed under the trade name Rescula for the management of open-angle glaucoma and ocular hypertension.
Wikidata facts
- Mass
- 382.271924
Show 5 more facts
- chemical formula
- C₂₂H₃₈O₅
- isomeric SMILES
- CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O
- canonical SMILES
- CCCCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)O)O)O
- World Health Organisation international non-proprietary name
- unoprostone
- Commons category
- Unoprostone
Sources (6)
via Wikidata · CC0
~1 min read
Article
1 sectionsContents
- References
Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone isopropyl, was marketed under the trade name Rescula for the management of open-angle glaucoma and ocular hypertension.
It was approved by the Food and Drug Administration in 2000.In 2009, Sucampo Pharmaceuticals acquired the rights to the drug in the U.S. and Canada.
Available in 10 languages
via Wikidata sitelinks · CC0